These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25229174)

  • 21. [Drug-induced reversible cerebral vasoconstriction syndrome : Ustekinumab as possible trigger?].
    Schmidbauer ML; Wollenweber FA; Straube A; Kamm K
    Schmerz; 2020 Aug; 34(4):350-353. PubMed ID: 32435940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: a variant of the reversible cerebral vasoconstriction syndrome?
    Wolff V; Armspach JP; Lauer V; Rouyer O; Ducros A; Marescaux C; Gény B
    Cerebrovasc Dis; 2015; 39(1):31-8. PubMed ID: 25547150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoricoxib-induced erythema-multiforme-like eruption.
    Thirion L; Nikkels AF; Piérard GE
    Dermatology; 2008; 216(3):227-8. PubMed ID: 18182814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible cerebral vasoconstriction syndrome in association with fingolimod use.
    Belliston S; Sundararajan J; Hammond N; Newell K; Lynch S
    Int J Neurosci; 2017 Sep; 127(9):831-834. PubMed ID: 27819760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.
    Bouchard M; Verreault S; Gariépy JL; Dupré N
    Headache; 2009 Jan; 49(1):142-5. PubMed ID: 18647181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal exfoliation as a selective reaction to etoricoxib.
    Patanè M; Isola S; Gangemi S; Minciullo PL
    J Clin Pharm Ther; 2016 Dec; 41(6):722-724. PubMed ID: 27576781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report on toxic epidermal necrolysis with etoricoxib.
    Kameshwari JS; Devde R
    Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
    Wong EH; Leung TW; Wong KS
    J Neuroimaging; 2007 Jan; 17(1):87-8. PubMed ID: 17238877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent thunderclap headaches and multilobar intracerebral haemorrhages: two cases of reversible cerebral vasoconstriction syndrome (RCVS).
    Wong SH; Dougan C; Chatterjee K; Fletcher NA; White RP
    Cephalalgia; 2009 Jul; 29(7):791-5. PubMed ID: 19220301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible cerebral vasoconstriction syndrome precipitated by airplane descent: Case report.
    Hiraga A; Aotsuka Y; Koide K; Kuwabara S
    Cephalalgia; 2017 Oct; 37(11):1102-1105. PubMed ID: 27521842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.
    Ducros A; Boukobza M; Porcher R; Sarov M; Valade D; Bousser MG
    Brain; 2007 Dec; 130(Pt 12):3091-101. PubMed ID: 18025032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible cerebral vasoconstriction syndrome secondary to caffeine withdrawal.
    Kalladka D; Siddiqui A; Tyagi A; Newman E
    Scott Med J; 2018 Feb; 63(1):22-24. PubMed ID: 28480791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible cerebral vasoconstriction syndrome as a cause of thunderclap headache: a retrospective case series study.
    Papathanasiou A; Zouvelou V; Breen DP; Phillips TJ; Misbahuddin A; Chawda S; de Silva R
    Am J Emerg Med; 2015 Jun; 33(6):859.e3-6. PubMed ID: 25583268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible cerebral vasoconstriction syndrome: a rare entity in children presenting with thunderclap headache.
    Ghosh PS; Rothner AD; Zahka KG; Friedman NR
    J Child Neurol; 2011 Dec; 26(12):1580-4. PubMed ID: 21750351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology of etoricoxib.
    Capone ML; Tacconelli S; Patrignani P
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):269-82. PubMed ID: 16922642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.
    Krum H; Swergold G; Curtis SP; Kaur A; Wang H; Smugar SS; Weir MR; Laine L; Brater DC; Cannon CP
    J Hypertens; 2009 Apr; 27(4):886-93. PubMed ID: 19516186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible cerebral vasoconstriction syndrome with increased intracranial pressure, probably related to altitude changes and windy winter travelling.
    Tienviboon C; Punyagupta S; Pongtarakulpanit A; Prichanond S
    J Med Assoc Thai; 2011 May; 94(5):622-8. PubMed ID: 21675454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible cerebral vasoconstriction syndrome identification of prognostic factors.
    Robert T; Kawkabani Marchini A; Oumarou G; Uské A
    Clin Neurol Neurosurg; 2013 Nov; 115(11):2351-7. PubMed ID: 24021453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical worsening in reversible cerebral vasoconstriction syndrome.
    Katz BS; Fugate JE; Ameriso SF; Pujol-Lereis VA; Mandrekar J; Flemming KD; Kallmes DF; Rabinstein AA
    JAMA Neurol; 2014 Jan; 71(1):68-73. PubMed ID: 24190097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.